US Stock MarketDetailed Quotes

LYRA Lyra Therapeutics

Watchlist
  • 0.159
  • -0.001-0.44%
Close Mar 19 16:00 ET
  • 0.163
  • +0.004+2.27%
Post 20:01 ET
10.47MMarket Cap-0.11P/E (TTM)

About Lyra Therapeutics Company

Lyra Therapeutics, Inc. is a clinical-stage therapeutics company. It develops novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat, or ENT, diseases. The firms proprietary XTreo deliver medicines. The company was founded by Carmichael S. Roberts, George M. Whitesides, and Robert S. Langer in November 2005 and is headquartered in Watertown, MA.

Company Profile

SymbolLYRA
Company NameLyra Therapeutics
Listing DateMay 1, 2020
Issue Price16.00
Founded2005
CEODr. Maria Palasis, PhD
MarketNASDAQ
Employees145
Fiscal Year Ends12-31
Address480 Arsenal Way
CityWatertown
ProvinceMassachusetts
CountryUnited States of America
Zip Code02472
Phone1-617-393-4600
Websitehttp://www.lyratherapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Maria Palasis, PhD
  • Director, President and Chief Executive Officer
  • 3.73M
  • Jason Cavalier
  • Chief Financial Officer, Treasurer and Principal Accounting Officer
  • 1.30M
  • Dr. Harlan W. Waksal,M.D.
  • Executive Chairman of the Board
  • 2.80M
  • Dr. Nancy L. Snyderman, F.A.C.S.,M.D.
  • Independent Director
  • 62.73K
  • W. Bradford Smith
  • Independent Director
  • 72.17K
  • C. Ann Merrifield
  • Independent Director
  • 61.42K
  • James R. Tobin
  • Lead Independent Director
  • 100.67K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
Jiangxi Jiangnan New Material Technology
603124
+640.04%
Ningbo Daye Garden Machinery
300879
+20.02%
Shaoyang Victor Hydraulics
301079
+20.02%
4
Baoding Dongli Machinery
301298
+20.00%
5
Fujian Superpipe
300198
+20.00%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
🎙️Discussion1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovati Show More
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings